← Evidence map

ArticleMetabolic brain disease2026

AMPK activation by Aldometanib from Bigujing improves metabolic and cognitive dysfunction in aging mice.

Xiaoyu Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42730893